指南与共识流行病学与生物统计医学教育与科研方法

妊娠期缺铁与缺铁性贫血的筛查及补充:美国预防服务工作组推荐声明

Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy: US Preventive Services Task Force Recommendation Statement.
指南 / 共识 · JAMA · 2024-01-01

美国预防服务工作组(USPSTF)基于系统综述评估无症状孕妇缺铁(伴或不伴贫血)筛查与补充对母婴健康结局的获益与危害。工作组认为现有证据不足以判定筛查和常规补充的获益与危害平衡,两项均给出I级声明。

要点

  • 妊娠期缺铁总体估计患病率近18%,三个孕期分别为6.9%、14.3%、28.4%。
  • 估计5%孕妇患有缺铁性贫血。
  • USPSTF认为证据不足以评估无症状孕妇筛查和常规补充缺铁的获益与危害平衡(I级声明)。

核心结论

  • USPSTF认为现有证据不足以评估孕妇筛查缺铁和缺铁性贫血以预防母婴不良结局的获益与危害平衡(I级声明)。
  • USPSTF认为现有证据不足以评估孕妇常规补充以预防缺铁和缺铁性贫血相关母婴不良结局的获益与危害平衡(I级声明)。

研究设计与样本

  • USPSTF委托开展系统综述,评估无症状孕妇筛查和补充缺铁(伴或不伴贫血)对母婴健康结局的获益与危害证据。
  • 目标人群为无症状的妊娠青少年和成人。

主要发现

  • 据1999年至2006年调查数据,妊娠期缺铁总体估计患病率近18%,三个孕期分别为6.9%、14.3%、28.4%。
  • 估计5%孕妇患有缺铁性贫血。
  • USPSTF结论为现有证据不足以判定筛查和补充的获益与危害平衡。

关键数值与推荐

  • 筛查缺铁和缺铁性贫血以预防母婴不良结局:I级声明(证据不足)。
  • 常规补充以预防缺铁和缺铁性贫血相关母婴不良结局:I级声明(证据不足)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Iron deficiency is the leading cause of anemia during pregnancy. According to survey data from 1999 to 2006, overall estimated prevalence of iron deficiency during pregnancy is near 18% and increases across the 3 trimesters of pregnancy (from 6.9% to 14.3% to 28.4%). An estimated 5% of pregnant persons have iron deficiency anemia. OBJECTIVE: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the evidence on the benefits and harms of screening and supplementation for iron deficiency with and without anemia on maternal and infant health outcomes in asymptomatic pregnant persons. POPULATION: Asymptomatic pregnant adolescents and adults. EVIDENCE ASSESSMENT: The USPSTF concludes that the current evidence is insufficient, and the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in asymptomatic pregnant persons on maternal and infant health outcomes cannot be determined. The USPSTF also concludes that the current evidence is insufficient, and the balance of benefits and harms of iron supplementation in asymptomatic pregnant persons on maternal and infant health outcomes cannot be determined. RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine supplementation for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes. (I statement).

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Nicholson WK, Silverstein M, Wong JB, et al. Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy: US Preventive Services Task Force Recommendation Statement. JAMA. 2024. PMID: 39163015. doi:10.1001/jama.2024.15196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。